Barrett & Company’s Zimmer Biomet ZBH Stock Holding History

Barrett & Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Hold	20	–	–	﹤0.01%	637
2026 Q1	$1.81K	Hold	20	–	–	﹤0.01%	590
2025 Q4	$1.8K	Hold	20	–	–	﹤0.01%	593
2025 Q3	$1.97K	Hold	20	–	–	﹤0.01%	586
2025 Q2	$1.82K	Hold	20	–	–	﹤0.01%	590
2025 Q1	$2.26K	Hold	20	–	–	﹤0.01%	549
2024 Q4	$2.11K	Hold	20	–	–	﹤0.01%	552
2024 Q3	$2.16K	Hold	20	–	–	﹤0.01%	531
2024 Q2	$2.17K	Hold	20	–	–	﹤0.01%	541
2024 Q1	$2.64K	Hold	20	–	–	﹤0.01%	532
2023 Q4	$2.43K	Hold	20	–	–	﹤0.01%	522
2023 Q3	$2.24K	Hold	20	–	–	﹤0.01%	538
2023 Q2	$2.91K	Hold	20	–	–	﹤0.01%	509
2023 Q1	$2.58K	Hold	20	–	–	﹤0.01%	494
2022 Q4	$2.55K	Hold	20	–	–	﹤0.01%	501
2022 Q3	$2.55K	Buy	+20	New	+$2.19K	﹤0.01%	501

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrett & Company's ZBH Position: Q2 2026 in Review

Barrett & Company held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 20 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Barrett & Company first reported a position in ZBH in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.91K in Q2 2023. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Barrett & Company held 20 shares of Zimmer Biomet worth $1.72K as of Q2 2026.
Barrett & Company left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #637 holding.
Barrett & Company first reported a position in Zimmer Biomet in Q3 2022 and has held it in 16 quarters since.
Barrett & Company's Zimmer Biomet position peaked at $2.91K in Q2 2023.
910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.